FY2025 · ended Dec 31, 2025 · Revenue $85.23M, +129.1% YoY · Filed Feb 26, 2026
Delcath Systems, Inc. (DCTH) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $85.2 million and net income of $2.7 million. Free cash flow was $21.0 million. As of Jun 30, 2026 it held $95.9 million in cash and investments and $2.5 million in total debt.
Revenue (TTM)
$95.42M
+35.8% vs year-ago TTM
Net income (TTM)
$532,000
-76.2% vs year-ago TTM
Operating cash flow (TTM)
$19.59M
+303.9% vs year-ago TTM
Free cash flow (TTM)
$17.51M
+352.7% vs year-ago TTM
EPS (TTM)
$0.01
-79.0% vs year-ago TTM
Dividend per share
None
Shares outstanding
34.75M
+4.0% vs prior year
Net cash
$93.44M
as of Jun 30, 2026
Operating margin
-1.9%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- DCTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Queensbury, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 872912
- Former names
- DELCATH SYSTEMS, INC. (until Oct 27, 2026); DELCATH SYSTEMS INC (until Apr 22, 2013)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $85.2M | $37.2M | $2.1M | $2.7M | — |
| Operating income | $660,000 | -$12.4M | -$38.2M | -$33.9M | -$24.5M |
| Net income | $2.7M | -$26.4M | -$47.7M | -$36.5M | -$25.6M |
| Diluted EPS | $0.07 | -$0.93 | -$2.94 | -$4.12 | — |
| Operating cash flow | $22.5M | -$18.7M | -$31.3M | -$24.9M | -$22.6M |
| Free cash flow | $21.0M | -$19.2M | -$31.3M | -$25.2M | -$22.7M |
| Total assets | $123.6M | $76.6M | $38.6M | $17.9M | $33.1M |
| Total liabilities | $12.4M | $7.8M | $22.8M | $23.7M | $21.2M |
| Stockholders' equity | $111.2M | $68.7M | $15.8M | -$5.9M | $12.0M |
| Cash and investments | $91.0M | $53.2M | $32.5M | $7.7M | $22.8M |
| Total debt | $936,000 | $1.0M | $10.3M | $268,000 | $623,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 14, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 14, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
All 1000 Delcath Systems, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.